C18ORF32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.29194441203617E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.20939966111678E-10 |
Normal-vs-Stage2 |
2.966400E-02 |
Normal-vs-Stage3 |
6.66133814775094E-16 |
Normal-vs-Stage4 |
1.62481139653892E-12 |
Stage1-vs-Stage2 |
2.566400E-01 |
Stage1-vs-Stage3 |
3.804100E-03 |
Stage1-vs-Stage4 |
4.365400E-04 |
Stage2-vs-Stage3 |
2.302100E-02 |
Stage2-vs-Stage4 |
1.380070E-02 |
Stage3-vs-Stage4 |
6.764600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.02424751907893E-12 |
Normal-vs-AfricanAmerican |
2.50410803204204E-12 |
Normal-vs-Asian |
1.609770E-04 |
Caucasian-vs-AfricanAmerican |
3.725800E-01 |
Caucasian-vs-Asian |
3.609400E-01 |
AfricanAmerican-vs-Asian |
2.338400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.21478391182472E-12 |
Normal-vs-Female |
3.4939995341432E-10 |
Male-vs-Female |
5.243000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.13089546008405E-11 |
Normal-vs-Age(41-60Yrs) |
2.0690005264612E-11 |
Normal-vs-Age(61-80Yrs) |
1.73416836446449E-12 |
Normal-vs-Age(81-100Yrs) |
8.469500E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.528000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.065370E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.431210E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.692600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.887200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.418400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.50830000045232E-07 |
Normal-vs-Grade 2 |
1.18640000046355E-07 |
Normal-vs-Grade 3 |
1.66533453693773E-15 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
2.465800E-01 |
Grade 1-vs-Grade 3 |
1.254790E-01 |
Grade 1-vs-Grade 4 |
2.739200E-03 |
Grade 2-vs-Grade 3 |
5.769000E-04 |
Grade 2-vs-Grade 4 |
2.12920003850314E-09 |
Grade 3-vs-Grade 4 |
3.041900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.60929999992732E-07 |
Normal-vs-ccB subtype |
4.7795101210113E-13 |
ccA subtype-vs-ccB subtype |
2.975200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.89189774957299E-11 |
Normal-vs-N1 |
2.40370000015311E-07 |
N0-vs-N1 |
1.930810E-01 |
|
|